Researchers at the University of Manchester and the Salford Royal NHS Foundation Trust have created a drug called Kineret that can treat rheumatoid arthritis. The injection (subcutaneously) had no side effects.
Kineret blocks the action of the IL-1 protein that is released into the body as a result of inflammation caused by a stroke, writes Science Daily.
Scientists mention in the study published in the journal Stroke that for the time being I cannot know exactly what impact the reduction of inflammation will have on patients.
However, given that stroke is one of the most common problems in adults, a new drug that reduces the negative effects and therefore increases the chances of an optimal recovery is essential in avoiding other health problems that may occur in the future.
“Although strokes affects different people in different ways, for many there is a devastating long-term effect. Excessive inflammation can be extremely harmful and can indicate a more serious consequence in patients, “said Craig Smith of the University of Manchester, one of the study’s authors. “We have shown that injections of Kineret, started no later than six hours after the stroke, reduce the levels of inflammation in patients.”
Read the rest of the material on discover.ro.